Treating Alzheimer’s Very Early Offers Better Hope of Slowing Decline, Study Finds

A trial of donanemab, an experimental drug, found it modestly slowed the worsening of memory and thinking and worked better in patients at earlier stages and those under 75.

Ozempic y su efecto en ‘ruido de la comida’

En redes sociales, algunas personas que toman estos fármacos dicen que uno de los efectos que experimentan es dejar de pensar constantemente en lo que van a comer.

How Women Feel About an Over-the-Counter Birth Control Pill

Most potential consumers were excited by the prospect, though sticker price and safety were lingering concerns.

F.D.A. Approves First U.S. Over-the-Counter Birth Control Pill

The price of the pill, which has not been announced, will determine how affordable it will be when it becomes available in early 2024.

Schumer Asks Judicial Policymakers to End Single-Judge Divisions in Texas

The letter is the latest push by Democratic lawmakers to amend a system in which all cases filed in a particular geographic region are assigned to only one judge.

Substance Abuse Is Climbing Among Seniors

Many aging baby boomers have long histories with drugs, cannabis and alcohol. “The field wasn’t ready for that,” said one expert.

Leqembi: lo que hay que saber sobre el fármaco contra el alzhéimer

Medicare cubrirá gran parte del costo para los pacientes en las primeras fases de la enfermedad, pero esta medicina tiene algunos riesgos y solo ralentiza modestamente el deterioro cognitivo.

Antibiotic Shortage Could Fuel Rise in Syphilis Rates

The primary drug used to treat the sexually transmitted infection could be scarce into next year, Pfizer warns.

What to Know About Leqembi, the Alzheimer’s Drug Approved by the FDA

Medicare will cover much of the cost for patients in the early stages of the disease, but Leqembi has safety risks and can only modestly slow cognitive decline.

FDA Makes Alzheimer’s Drug Leqembi Widely Accessible

The F.D.A. gave full approval to the drug, but added a black-box warning about safety risks. Medicare said it would cover most of the high cost.